Absent or insufficient parathyroid hormone (PTH) leads to hypocalcemia, hyperphosphatemia, and an inability to convert vitamin D to its active form, 1,25(OH)2 vitamin D. Patients are generally treated with calcium (Ca) and calcitriol to maintain Ca levels. This evidence concerns the gene PTH and hyperphosphatemia.